AAAAAA
Results: 1-25/53
Authors:
BJORKQVIST AM
HUSGAFVELPURSIAINEN K
ANTTILA S
KARJALAINEN A
TAMMILEHTO L
MATTSON K
VAINIO H
KNUUTILA S
Citation: Am. Bjorkqvist et al., DNA GAINS IN 3Q OCCUR FREQUENTLY IN SQUAMOUS-CELL CARCINOMA OF THE LUNG, BUT NOT IN ADENOCARCINOMA, Genes, chromosomes & cancer, 22(1), 1998, pp. 79-82
Authors:
KAHLOS K
ANTTILA S
ASIKAINEN T
KINNULA K
RAIVIO KO
MATTSON K
LINNAINMAA K
KINNULA VL
Citation: K. Kahlos et al., MANGANESE SUPEROXIDE-DISMUTASE IN HEALTHY-HUMAN PLEURAL MESOTHELIUM AND IN MALIGNANT PLEURAL MESOTHELIOMA, American journal of respiratory cell and molecular biology, 18(4), 1998, pp. 570-580
Authors:
SANDLER A
DENHAM C
VONPAWEL J
CORMIER Y
GATZEMEIER U
MATTSON K
MANEGOLD C
GREGOR A
BLATTER J
EINHORN L
Citation: A. Sandler et al., SIGNIFICANTLY HIGHER SURVIVAL WITH GEMCITABINE-CISPLATIN VS CISPLATININ ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - FINAL RESULTS FROM ANINTERNATIONAL RANDOMIZED PHASE-III STUDY, Annals of oncology, 9, 1998, pp. 409-409
Authors:
LECHEVALIER T
MATTSON K
BOSQUEE L
BERILLE J
OLIVARES R
BRAGAS B
Citation: T. Lechevalier et al., CLINICAL AND BIOLOGICAL PROGNOSTIC FACTORS FOR RESPONSE RATE (RR), TIME TO PROGRESSION (TTP) AND SURVIVAL (OS) IN 203 PATIENTS (PTS) WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER TREATED WITH TAXOTERE(R), Annals of oncology, 9, 1998, pp. 418-418
Authors:
MATTSON K
MANEGOLD C
POSTMUS P
SMIT E
MILLWARD M
SAARINEN A
Citation: K. Mattson et al., PHASE-II TRIAL OF THE MULTITARGETED ANTIFOLATE MTA (LY231514) IN PATIENTS WITH NONSMALL CELL LUNG-CANCER (NSCLC) WHO HAVE FAILED PREVIOUS PLATINUM OR NONPLATINUM CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 472-472
Authors:
KNUUTTILA A
HALME M
JEKUNEN A
MATTSON K
Citation: A. Knuuttila et al., A PHASE-II STUDY IN THE TREATMENT OF MESOTHELIOMA WITH A COMBINATION OF DOCETAXEL AND CPT-11 - SET-UP AND INITIAL RESULTS, Annals of oncology, 9, 1998, pp. 667-667
Authors:
ISOKANGAS OP
JOENSUU H
HALME M
JEKUNEN A
MATTSON K
Citation: Op. Isokangas et al., PACLITAXEL (TAXOL(R)) AND CARBOPLATIN FOLLOWED BY CONCOMITANT PACLITAXEL, CISPLATIN AND RADIOTHERAPY FOR INOPERABLE STAGE-III NSCLC, Lung cancer, 20(2), 1998, pp. 127-133
Authors:
MATTSON K
Citation: K. Mattson, MENTORING OUTSIDE THE IVORY TOWER (HISTORY, ADULT-EDUCATION), Radical history review, (72), 1998, pp. 32-38
Authors:
SALVEN P
RUOTSALAINEN T
MATTSON K
JOENSUU H
Citation: P. Salven et al., HIGH PRETREATMENT SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) IS ASSOCIATED WITH POOR OUTCOME IN SMALL-CELL LUNG-CANCER, International journal of cancer, 79(2), 1998, pp. 144-146
Authors:
MATTSON K
TAMMINEN K
NIKKANEN V
VIREN M
ISOKANGAS OP
DELGADO FM
BARBET I
Citation: K. Mattson et al., A FEASIBILITY STUDY OF VINORELBINE (VNR) AND GEMCITABINE (GEM) IN INOPERABLE STAGE IIIB-IV NSCLC, British Journal of Cancer, 78, 1998, pp. 12-12
Authors:
BJORKQVIST AM
TAMMILEHTO L
NORDLING S
NURMINEN M
ANTTILA S
MATTSON K
KNUUTILA S
Citation: Am. Bjorkqvist et al., COMPARISON OF DNA COPY NUMBER CHANGES IN MALIGNANT MESOTHELIOMA, ADENOCARCINOMA AND LARGE-CELL ANAPLASTIC CARCINOMA OF THE LUNG, British Journal of Cancer, 77(2), 1998, pp. 260-269
Authors:
JUMPPONEN A
MATTSON K
TRAPPE JM
OHTONEN R
Citation: A. Jumpponen et al., EFFECTS OF ESTABLISHED WILLOWS ON PRIMARY SUCCESSION ON LYMAN GLACIERFOREFRONT, NORTH CASCADE RANGE, WASHINGTON, USA - EVIDENCE FOR SIMULTANEOUS CANOPY INHIBITION AND SOIL FACILITATION, Arctic and alpine research, 30(1), 1998, pp. 31-39
Authors:
MATTSON K
NIIRANEN A
RUOTSALAINEN T
MAASILTA P
HALME M
PYRHONEN S
KAJANTI M
MANTYLA M
TAMMINEN K
JEKUNEN A
SARNA S
CANTELL K
Citation: K. Mattson et al., INTERFERON MAINTENANCE THERAPY FOR SMALL-CELL LUNG-CANCER - IMPROVEMENT IN LONG-TERM SURVIVAL, Journal of interferon & cytokine research, 17(2), 1997, pp. 103-105
Authors:
JOENSUU H
SALVEN P
RUOTSALAINEN T
MATTSON K
Citation: H. Joensuu et al., A HIGH PRETREATMENT SERUM LEVEL OF VEGF IS ASSOCIATED WITH POOR OUTCOME IN SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 188-188
Authors:
MATTSON K
OLLIKAINEN T
HIRVONEN A
HALME M
KNUUTTILA A
JEKUNEN A
LINNAINMAA K
Citation: K. Mattson et al., MALIGNANT MESOTHELIOMA - IN-VITRO RESPONSES TO NEW CHEMOTHERAPEUTIC-AGENTS, AND CORRELATION TO GSTM1 AND NAT2 GENE POLYMORPHISM, European journal of cancer, 33, 1997, pp. 782-782
Authors:
MATTSON K
LECHEVALIER T
BOSQUEE L
PUJOL JL
CULINE S
DABOUIS G
LEGROUMELLEC A
STUPP R
BOYER R
BERILLE J
Citation: K. Mattson et al., INTERIM RESULTS OF A PHASE-II STUDY OF DOCETAXEL (TAXOTERE(R)) IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) ON 204 CHEMOTHERAPY NAIVE OR PRETREATED PATIENTS, European journal of cancer, 33, 1997, pp. 1036-1036
Authors:
MATTSON K
TAMMINEN K
NIKKANEN V
VIREN M
ISOKANGAS OP
LEBRAS F
BARBET I
Citation: K. Mattson et al., A FEASIBILITY STUDY OF VINORELBINE (VNR) AND GEMCITABINE (GEM) IN INOPERABLE STAGE IIIB-IV NSCLC, European journal of cancer, 33, 1997, pp. 1066-1066
Authors:
SAHMOUD T
POSTMUS PE
VANPOTTELSBERGHE C
MATTSON K
TAMMILEHTO L
SPLINTER TAW
PLANTING AST
SUTEDJA T
VANPAWEL J
VANZANDWIJK N
BAAS P
ROOZENDAAL KJ
SCHRIJVER M
KIRKPATRICK A
VANGLABBEKE M
ARDIZZONI A
GIACCONE G
Citation: T. Sahmoud et al., ETOPOSIDE IN MALIGNANT PLEURAL MESOTHELIOMA - 2 PHASE-II TRIALS OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, European journal of cancer, 33(13), 1997, pp. 2211-2215
Authors:
HALME M
JEKUNEN A
TAMMINEN K
MATTSON K
Citation: M. Halme et al., PHASE-II STUDY OF WEEKLY GEMCITABINE IN ADVANCED NONSMALL CELL LUNG-CANCER, Respiratory medicine, 91(7), 1997, pp. 423-426
Authors:
MANEGOLD C
BERGMAN B
CHEMAISSANI A
DORNOFF W
DRINGS P
KELLOKUMPULEHTINEN P
LIIPPO K
MATTSON K
VONPAWEL J
RICCI S
SEDERHOLM C
STAHEL RA
WAGENIUS G
VONWALREE N
TENBOKKELHUININK W
Citation: C. Manegold et al., SINGLE-AGENT GEMCITABINE VERSUS CISPLATIN-ETOPOSIDE - EARLY RESULTS OF A RANDOMIZED PHASE-II STUDY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(6), 1997, pp. 525-529
Authors:
KARJALAINEN A
PUKKALA E
MATTSON K
TAMMILEHTO L
VAINIO H
Citation: A. Karjalainen et al., TRENDS IN MESOTHELIOMA INCIDENCE AND OCCUPATIONAL MESOTHELIOMAS IN FINLAND IN 1960-1995, Scandinavian journal of work, environment & health, 23(4), 1997, pp. 266-270
Authors:
HOLSTI LR
PYRHONEN S
KAJANTI M
MANTYLA M
MATTSON K
MAASILTA P
KIVISAARI L
Citation: Lr. Holsti et al., ALTERED FRACTIONATION OF HEMITHORAX IRRADIATION FOR PLEURAL MESOTHELIOMA AND FAILURE PATTERNS AFTER TREATMENT, Acta oncologica, 36(4), 1997, pp. 397-405
Authors:
KLASTERSKY J
CULLEN M
SAUSE B
BALL D
DARWISH S
DOUILLARD J
KOMAKI R
MATTSON K
MIRIMANOFF R
REBOUL F
SAUNDERS M
SUTEDJA T
EVERETT EV
Citation: J. Klastersky et al., CONCURRENT TREATMENTS AND INDUCTION TREATMENTS FOR UNRESECTABLE TUMORS, Lung cancer, 17, 1997, pp. 27-28
COMBINATION TREATMENT WITH DOCETAXEL (TAXOTERE) AND PLATINUM COMPOUNDS FOR NONSMALL CELL LUNG-CANCER
Authors:
MATTSON K
SAARINEN A
JEKUNEN A
Citation: K. Mattson et al., COMBINATION TREATMENT WITH DOCETAXEL (TAXOTERE) AND PLATINUM COMPOUNDS FOR NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 5-8
Authors:
MANEGOLD C
DRINGS P
VONPAWEL J
RICCI S
DORNOFF W
VANWALREE N
HUININK WT
CHEMAISSANI A
STAHEL P
BERGMAN B
WAGENIUS G
SEDERHOLM C
MATTSON K
LIIPPO K
KELLOKUMPULEHTINEN P
Citation: C. Manegold et al., A RANDOMIZED STUDY OF GEMCITABINE MONOTHERAPY VERSUS ETOPOSIDE CISPLATIN IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 24(3), 1997, pp. 813-817